Global Coalition on Aging Calls on Policy-Makers to Address Cardiovascular Disease to Promote Healthy Aging

(New York – 1 April 2019) – Today, the Global Coalition on Aging (GCOA), in collaboration with Bayer, released a new report titled Healthy Heart for Healthy Aging: The Need for Awareness, Innovation, and Collaboration in Cardiovascular Health, which examines the cardiovascular health imperative aligned with population aging.

The report highlights the current momentum from the global health community that makes now the opportune time to advance a healthy aging agenda for cardiovascular diseases. The report calls for specific policy actions that will advance ongoing innovation and engage a wide range of stakeholders.

“As the prevalence of cardiovascular diseases rise with the aging of the population – already 1 billion of us over 60 globally and growing to 2 billion by mid-century – now is the time for action,” said Michael W. Hodin, PhD, CEO of GCOA. “We’ve seen incredible innovations in cardiovascular health over the past 50 years, yet CVDs remain the number one cause of death globally.  Unfortunately, this trend will continue with increasing longevity unless policy-makers and public health leaders commit to alleviating the impacts on patients, health systems, economies and society.”

With over 17 million deaths worldwide, CVDs are the largest noncommunicable disease (NCD) by morbidity and mortality. From 1990 to 2016, the number of global, annual CVD deaths increased by more than 40% – from around 12 million to over 17 million – increasing CVDs’ share of total mortality from 27% to 32% of all deaths. CVDs impose an immense burden on individuals and health systems, due to the costs of the diseases and their comorbidities. Yet too often, these diseases are misunderstood as a natural condition of becoming old when in fact proactive attention to prevention, treatments, and care can change the incidence and prevalence of these conditions regardless of age.

“Over the past decades, innovative treatments have contributed to an increase of the average life span. As we continue to see rapidly aging populations around the world, effectively tackling and managing age-related illnesses have become pivotal,” said Dr. Michael Devoy, Chief Medical Officer of Bayer AG. “We have to focus on addressing these unmet needs, by embracing the opportunities around scientific progress and innovation in order to establish a sustainable framework for the future.”

The report calls for action in three areas:

  • Awareness: Meaningful policy action on CVDs must promote awareness and education amongst the public, patients, caregivers, and healthcare professionals to empower healthy choices that reduce risk for CVDs and related health challenges.
  • Innovation: Policy-makers must recognize that innovation moves primarily through incremental advances, so we must accept a research paradigm aligned with this stepwise progression.
  • Collaboration: Effectively addressing the direct and indirect impacts of CVDs will require policies and platforms that engage a wide range of actors, including government agencies, health systems, the private sector, non-profits, multilateral organizations, and advocacy groups.

In recent years, leading global, multilateral, and national institutions and health policy decision-makers – including the WHO, OECD, G20, governments, and others – have recognized the need to address the growing health and economic challenges related to population aging. Landmark public policy initiatives, like WHO’s Decade of Healthy Ageing and the G20 Principles on Silver Economy and Active Aging, have generated global momentum for successful aging. Now, policy-makers must continue this momentum to establish frameworks, programs, and collaborations that realize a sustainable course for healthy and active aging, and CVDs require urgent attention.

“The rise in cardiovascular disease should serve as a major call to action for policy-makers, the health sector, patient advocates, and the public,” said Dr. Holly S. Andersen, MD, Director of Education and Outreach, Ronald O. Perelman Heart Institute. “Innovations in healthcare, medicine, and technology have brought us longer lives, but the next era of innovation is needed as a driver of longer – and healthier – lives.”

To read the full report, click here.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

A Bipartisan Bill Could Prevent The Next Pandemic

In Washington, Republicans and Democrats are typically at loggerheads when it comes to healthcare policy. Just consider the recent Inflation Reduction Act, which made extensive changes to Medicare and also extended Affordable Care Act subsidies. Every single congressional Democrat voted for the legislation, while every single member of the GOP voted against it. But occasionally, a bill is such an obviously good idea, and so desperately needed, that it commands significant bipartisan support. The PASTEUR Act, co-sponsored by 31 Democrats and 31 Republicans in the House and two members of each party in the Senate, is just such a bill.

Korea Must Act Now to Combat Growing AMR Threat

Public officials are overlooking one of the gravest long-term threats to the Korean people, the health system, and economy: antimicrobial resistance (AMR). Some pathogens ― bacteria, fungi, parasites, and viruses ― have evolved strains that resist the antimicrobial medications we currently have available to fight them. Health care professionals often must watch helplessly as patients succumb to infections that antibiotics could once have easily beaten. They know that new antimicrobials, including and especially antibiotics, could easily gain the victory ― but they have none at their disposal.

Policy Statement on the Impact of Price Negotiations on Innovation, Healthy Aging and Equity

As the CEO of the Global Coalition on Aging (GCOA) and a newly formed cross-sector Alliance for Health Innovation, we write to express our deep concern with the current legislation that allows for price “negotiations” in Medicare – a thinly veiled signal for America’s plunge into price controls that will have a devastating and adverse impact on biopharmaceutical innovation and our nations’ ability to support healthy aging. 

Ignoring the ‘Silver Economy’ May Be Getting Costly for Brands

In an ad for Airbnb that premiered earlier this year, a couple checks into a cozy Spanish villa. To the tune of Jay-Z's cover of "Me and My Girlfriend," the ad shows the pair settling into their rental and setting their collective dial to chill. They play ping-pong, sip some wine, and get ready for a night on the town. They're also in their 80s, celebrating their 57th wedding anniversary. In no way does the ad characterize the couple as elderly or portray them as needing special aid or services — they are just active people who happen to be old. It's a rare example of ads featuring a realistic depiction of aging.

Health Equity Promise and That Innovation Thing

President Biden has pledged his administration to defeat cancer, Alzheimer’s, and other diseases that target America’s aging population. To achieve these lofty goals, bold words must be backed up by bold actions.

Roundtable Report Highlights Importance of Immunizing Canada’s Caregivers Against Influenza, Identifying Challenges and Opportunities to Protect This Critical Group

The Global Coalition on Aging (GCOA) today released a report summarizing key insights from an expert roundtable on vaccinating Canada’s caregivers against influenza. The roundtable, held virtually, brought together leading Canadian health policy experts, family caregivers, patient advocacy groups, aging experts, and other thought leaders to discuss challenges and strategies to reach this critically important yet hard-to-reach group.